X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (859) 859
Paper (227) 227
Publication (121) 121
Report (112) 112
Book Review (25) 25
Conference Proceeding (22) 22
Book / eBook (14) 14
Book Chapter (7) 7
Patent (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (252) 252
physics (252) 252
cern lhc coll (244) 244
high energy physics - experiment (240) 240
experimental results (237) 237
particle physics (224) 224
physics - high energy physics - experiment (210) 210
index medicus (203) 203
cms (202) 202
13000 gev-cms (195) 195
p p: scattering (193) 193
hep (187) 187
p p: colliding beams (178) 178
high energy physics (158) 158
physics of elementary particles and fields (119) 119
phenomenology (112) 112
humans (103) 103
essential oil (100) 100
nuclear experiment (85) 85
background (78) 78
analysis (74) 74
hadron-hadron scattering (73) 73
scattering [p p] (72) 72
colliding beams [p p] (66) 66
essential oils (66) 66
chemistry, applied (64) 64
food science & technology (60) 60
particle physics - experiment (54) 54
biochemistry & molecular biology (50) 50
chemical-composition (50) 50
chemistry, medicinal (50) 50
male (50) 50
oils, volatile - chemistry (49) 49
supersymmetry (48) 48
transverse momentum: missing-energy (48) 48
channel cross section: upper limit (47) 47
female (44) 44
italy (44) 44
antioxidant activity (41) 41
final state:jet lepton (40) 40
middle aged (40) 40
chemistry, multidisciplinary (39) 39
aged (38) 38
animals (38) 38
bottom: particle identification (38) 38
cern lab (38) 38
hep-ex (38) 38
antioxidants (37) 37
gas chromatography-mass spectrometry (37) 37
mass dependence (37) 37
oils, volatile - pharmacology (35) 35
channel cross section: branching ratio: upper limit (34) 34
transverse momentum (32) 32
agricultural engineering (31) 31
agronomy (31) 31
essential-oil (31) 31
instrumentation and detectors (31) 31
toxicity (31) 31
antioxidant (30) 30
oils & fats (30) 30
adult (29) 29
jet: bottom (28) 28
mass spectrometry (27) 27
pharmacology & pharmacy (27) 27
z0: leptonic decay (27) 27
beyond standard model (26) 26
astrophysics (25) 25
cell line, tumor (25) 25
gc-ms (25) 25
kinematics (25) 25
muon: pair production (25) 25
physics, particles & fields (25) 25
bottom: pair production (24) 24
oncology (24) 24
plants (24) 24
resonance: production (24) 24
sesquiterpenes (24) 24
essential oil composition (23) 23
higgs particle: hadroproduction (23) 23
insecticides (23) 23
nuclear physics (23) 23
structure (23) 23
top: pair production (23) 23
antimicrobial activity (22) 22
cancer (22) 22
extracts (22) 22
gluino: mass: lower limit (22) 22
in-vitro (22) 22
chemotherapy (21) 21
final state:jet (21) 21
higgs particle: hadronic decay (21) 21
narrow resonance (21) 21
plant extracts - pharmacology (21) 21
stop: mass: lower limit (21) 21
chemical composition (20) 20
constituents (20) 20
gravitation (20) 20
high energy astrophysical phenomena (20) 20
research (20) 20
signature (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Propellants, Explosives, Pyrotechnics, ISSN 0721-3115, 10/2014, Volume 39, Issue 5, pp. 755 - 760
Journal Article
Propellants, Explosives, Pyrotechnics, ISSN 0721-3115, 07/2019
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, pp. e92147 - e92147
Introduction: Although cetuximab and panitumumab show an increased efficacy for patients with KRAS-NRAS-BRAF and PI3KCA wild-type metastatic colorectal cancer,... 
CELL LUNG-CANCER | ANAPLASTIC LYMPHOMA KINASE | PHASE-III TRIAL | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | CETUXIMAB | SOLID TUMORS | RAS MUTATIONS | MULTIDISCIPLINARY SCIENCES | KRAS | MONOCLONAL-ANTIBODIES | Demography | Membrane Proteins - genetics | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Male | Treatment Outcome | Gene Dosage | Transcription Factors - genetics | Disease-Free Survival | Receptor, Epidermal Growth Factor - metabolism | Receptor Protein-Tyrosine Kinases - genetics | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Adult | Female | Aged | Nuclear Proteins - genetics | Care and treatment | Patient outcomes | Colorectal cancer | Development and progression | Genetic aspects | Research | Biological markers | Securitization | Copy number | Lung cancer | Colorectal carcinoma | ALK protein | Raf protein | Oncology | Systematic review | Metastasis | Kinases | Cancer therapies | Clinical outcomes | K-Ras protein | Metastases | Signal transduction | Epidermal growth factor | DNA methylation | Deoxyribonucleic acid--DNA | Translocation | Epidermal growth factor receptors | Patients | Survival | Amplification | Pathology | Irinotecan | Gene amplification | Chemotherapy | Medical prognosis | Response rates | Biomarkers | Lymphomas | Tumors | Cancer | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2015, Volume 137, Issue 6, pp. 1467 - 1474
Journal Article
Medical Oncology, ISSN 1357-0560, 7/2015, Volume 32, Issue 7, pp. 1 - 10
Journal Article
Nature Communications, ISSN 2041-1723, 07/2015, Volume 6, Issue 1, pp. 7855 - 7855
The direct conversion of light into work allows the driving of micron-sized motors in a contactless, controllable and continuous way. Light-to-work conversion... 
MOTORS | PARTICLES | GRADIENTS | MULTIDISCIPLINARY SCIENCES | MICROSWIMMERS | PROPULSION | Actuation | Laser beams | Temperature effects | Light | Micromotors | Direct conversion
Journal Article
Journal Article
Propellants, Explosives, Pyrotechnics, ISSN 0721-3115, 10/2014, Volume 39, Issue 5, pp. 755 - 760
Aluminum is used as a metal fuel in energetic materials for the improvement of propulsion performance and density. Both nano‐sized and micrometer‐sized... 
Viscosity | Aluminum particles | Micrometric | Nanometric | HTPB | ENGINEERING, CHEMICAL | RHEOLOGICAL PROPERTIES | SUSPENSIONS | AGGLOMERATION | CHEMISTRY, APPLIED | Isocyanates | Powders | Fatty acids | Analysis | Curing | Specific surface | Nanostructure | Binders | Coatings | Density | Diisocyanates
Journal Article
Flavour and Fragrance Journal, ISSN 0882-5734, 05/2017, Volume 32, Issue 3, pp. 159 - 164
Smyrnium olusatrum L. is a horticultural crop cultivated during the Roman age for culinary and curative uses. The essential oil extracted from this plant (AEO)... 
formulation | chemical composition | DLS, stability | cytotoxicity | Alexanders | APOPTOSIS | CELLS | FOOD SCIENCE & TECHNOLOGY | COMPOUND | APIACEAE | DLS | ISOFURANODIENE | CHEMISTRY, APPLIED | DRUG-DELIVERY SYSTEMS | stability | Stability | Axonogenesis | Essential oils | Crystallization | Biocompatibility | Oils & fats | Chemical composition | Shelf life | Microemulsions | Biological activity | Chromatography | Plant extracts
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2016, Volume 14, Issue 1, pp. 125 - 125
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 08/2016, Volume 256, pp. 125 - 133
Thyme ( ) is used traditionally to prepare herbal remedies possessing expectorant, mucolytic, antitussive and antispasmodic properties. The aim of the present... 
Normal bronchial and tracheal epithelial cells (HBEpC/HTEpC) | NF-κB | Thymus vulgaris | Thymol | Anti-inflammatory | Lung cancer | RESPIRATORY-TRACT | ESSENTIAL OILS | BIOCHEMISTRY & MOLECULAR BIOLOGY | NECROSIS-FACTOR-ALPHA | NEUTROPHIL ELASTASE | RECEPTOR ANTAGONIST | MUC5AC | NF-kappa B | AIRWAYS MUCUS | MUCIN TRANSCRIPTION | LIPOPOLYSACCHARIDE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | NF-KAPPA-B | Lung Neoplasms - drug therapy | Plant Extracts - chemistry | Respiratory Mucosa - drug effects | Plant Extracts - pharmacology | Humans | Thymus Plant - chemistry | NF-kappa B - immunology | Trachea - drug effects | Bronchi - immunology | Bronchi - drug effects | Respiratory Mucosa - immunology | Cell Death - drug effects | Thymol - chemistry | Bronchi - cytology | Cell Line | Respiratory Mucosa - cytology | Trachea - cytology | Anti-Inflammatory Agents - pharmacology | Interleukin-1beta - immunology | Antineoplastic Agents, Phytogenic - chemistry | Trachea - immunology | Lung Neoplasms - immunology | Anti-Inflammatory Agents - chemistry | Lung - drug effects | Thymol - pharmacology | Cell Line, Tumor | Antineoplastic Agents, Phytogenic - pharmacology | Interleukin-8 - immunology | Lung - immunology | Pharmacy | Analysis | Medicine, Botanic | Mortality | Mucins | Respiratory agents | Medicine, Herbal | Diseases | Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 09/2015, Volume 80, Issue 3, pp. 581 - 588
AimsTriplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan is a standard therapy for metastatic colorectal cancer (CRC). Single nucleotide... 
colorectal cancer | irinotecan | single nucleotide polymorphisms | pharmacogenetics | fluoropyrimidines | 1ST-LINE TREATMENT | LEUCOVORIN | BEVACIZUMAB | GUIDELINES | TOXICITY | FLUOROURACIL | CAPECITABINE | 5-FLUOROURACIL | FOLFOXIRI | PHARMACOLOGY & PHARMACY | EXPRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fluorouracil - therapeutic use | Glucuronosyltransferase - genetics | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Dihydropyrimidine Dehydrogenase Deficiency - genetics | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Leucovorin - therapeutic use | Camptothecin - analogs & derivatives | Dihydropyrimidine Dehydrogenase Deficiency - etiology | Camptothecin - adverse effects | Glucuronosyltransferase - deficiency | Camptothecin - therapeutic use | Homozygote | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Heterozygote | Aged | MicroRNAs - genetics | Polymorphism, Single Nucleotide | Organoplatinum Compounds - therapeutic use | Dihydrouracil Dehydrogenase (NADP) - genetics | Organoplatinum Compounds - adverse effects | Antimitotic agents | Cancer patients | Care and treatment | Pharmacogenetics | Chemotherapy | Analysis | Colorectal cancer | Single nucleotide polymorphisms | Antineoplastic agents | Chromosomes | Cancer | Index Medicus
Journal Article
Journal Article